lncRNA TUG1 regulated CCND2, through EZH2-related miR-194-5p silencing, to promote the growth of bladder cancer cells and confer cisplatin resistance (Gan et al. 2019). This evidence concerns the gene TUG1 and urinary bladder cancer.